Literature DB >> 29534773

The changing HIV-1 genetic characteristics and transmitted drug resistance among recently infected population in Yunnan, China.

M Chen1, M H Jia1, Y L Ma1, H B Luo1, H C Chen1, C J Yang1, J Dai1, L Yang1, L J Dong1, R Lu1, L J Song1, Y Han1, J Y Lu1, A K L Cheung2, Z W Chen2, L Lu1.   

Abstract

Multiple human immunodeficiency virus (HIV)-1 genotypes in China were first discovered in Yunnan Province before disseminating throughout the country. As the HIV-1 epidemic continues to expand in Yunnan, genetic characteristics and transmitted drug resistance (TDR) should be further investigated among the recently infected population. Among 2828 HIV-positive samples newly reported in the first quarter of 2014, 347 were identified as recent infections with BED-captured enzyme immunoassay (CEIA). Of them, 291 were successfully genotyped and identified as circulating recombinant form (CRF)08_BC (47.4%), unique recombinant forms (URFs) (18.2%), CRF01_AE (15.8%), CRF07_BC (14.4%), subtype C (2.7%), CRF55_01B (0.7%), subtype B (0.3%) and CRF64_BC (0.3%). CRF08_BC and CRF01_AE were the predominant genotypes among heterosexual and homosexual infections, respectively. CRF08_BC, URFs, CRF01_AE and CRF07_BC expanded with higher prevalence in central and eastern Yunnan. The recent common ancestor of CRF01_AE, CRF07_BC and CRF08_BC dated back to 1983.1, 1992.1 and 1989.5, respectively. The effective population sizes (EPS) for CRF01_AE and CRF07_BC increased exponentially during 1991-1999 and 1994-1999, respectively. The EPS for CRF08_BC underwent two exponential growth phases in 1994-1998 and 2001-2002. Lastly, TDR-associated mutations were identified in 1.8% of individuals. These findings not only enhance our understanding of HIV-1 evolution in Yunnan but also have implications for vaccine design and patient management strategies.

Entities:  

Keywords:  China; HIV-1; Yunnan; molecular epidemiology; transmitted drug resistance

Mesh:

Year:  2018        PMID: 29534773      PMCID: PMC9134363          DOI: 10.1017/S0950268818000389

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   4.434


  7 in total

1.  The changing face of HIV in China.

Authors:  Lin Lu; Manhong Jia; Yanling Ma; Li Yang; Zhiwei Chen; David D Ho; Yan Jiang; Linqi Zhang
Journal:  Nature       Date:  2008-10-02       Impact factor: 49.962

2.  HIV-1 subtype C in China.

Authors:  C C Luo; C Tian; D J Hu; M Kai; T Dondero; X Zheng
Journal:  Lancet       Date:  1995-04-22       Impact factor: 79.321

3.  HIV-1 subtype E in Yunnan, China.

Authors:  H Cheng; J Zhang; J Capizzi; N L Young; T D Mastro
Journal:  Lancet       Date:  1994-10-01       Impact factor: 79.321

4.  Temporal and spatial dynamics of human immunodeficiency virus type 1 circulating recombinant forms 08_BC and 07_BC in Asia.

Authors:  Kok Keng Tee; Oliver G Pybus; Xiao-Jie Li; Xiaoxu Han; Hong Shang; Adeeba Kamarulzaman; Yutaka Takebe
Journal:  J Virol       Date:  2008-07-02       Impact factor: 5.103

5.  Emerging variability in HIV-1 genetics among recently infected individuals in Yunnan, China.

Authors:  Min Chen; Li Yang; Yanling Ma; Yingzhen Su; Chaojun Yang; Hongbing Luo; Huichao Chen; Ling Chen; Wenyun Yan; Yuhua Shi; Manhong Jia; Lin Lu
Journal:  PLoS One       Date:  2013-03-26       Impact factor: 3.240

6.  Dominance of HIV-1 subtype CRF01_AE in sexually acquired cases leads to a new epidemic in Yunnan province of China.

Authors:  Yong Zhang; Lin Lu; Lei Ba; Li Liu; Li Yang; Manhong Jia; Haibo Wang; Qing Fang; Yuhua Shi; Wenyun Yan; Guangcai Chang; Linqi Zhang; David D Ho; Zhiwei Chen
Journal:  PLoS Med       Date:  2006-11       Impact factor: 11.069

7.  Geographic origin and evolutionary history of China's two predominant HIV-1 circulating recombinant forms, CRF07_BC and CRF08_BC.

Authors:  Yi Feng; Yutaka Takebe; Huamian Wei; Xiang He; Jenny H Hsi; Zhenpeng Li; Hui Xing; Yuhua Ruan; Yao Yang; Fan Li; Jing Wei; Xingguang Li; Yiming Shao
Journal:  Sci Rep       Date:  2016-01-14       Impact factor: 4.379

  7 in total
  12 in total

1.  Construction of Machine Learning Models to Predict Changes in Immune Function Using Clinical Monitoring Indices in HIV/AIDS Patients After 9.9-Years of Antiretroviral Therapy in Yunnan, China.

Authors:  Bingxiang Li; Mingyu Li; Yu Song; Xiaoning Lu; Dajin Liu; Chenglu He; Ruixian Zhang; Xinrui Wan; Renning Zhang; Ming Sun; Yi-Qun Kuang; Ya Li
Journal:  Front Cell Infect Microbiol       Date:  2022-05-12       Impact factor: 6.073

2.  Clinical characteristics and outcomes in HIV-associated diffuse large B-cell lymphoma in China: A retrospective single-center study.

Authors:  Jiazhu Wu; Yi Miao; Chuan Qian; Pengfei Tao; Xicheng Wang; Xingqi Dong; Xia Li; Jincheng Lou; Jinhua Liang; Wei Xu; Jianyong Li; Haiyan Min
Journal:  J Cancer       Date:  2021-03-15       Impact factor: 4.207

3.  AIDS prevention and control in the Yunnan region by T cell subset assessment.

Authors:  Ya Li; Chenglu He; Zengpin He; Min Zhong; Dajin Liu; Ruiyang Liu; Ruixuan Fan; Yong Duan
Journal:  PLoS One       Date:  2019-04-18       Impact factor: 3.240

4.  A thematic analysis of experiences of HIV risks among female sex workers in the Yunnan-Vietnam Chinese border region.

Authors:  Amanda Wilson; Yuan Yuan Wang; Runsen Chen; Ping Cen; Yuehui Wang; Xing Yao; Tang Wang; Shiyue Li; Hong Yan
Journal:  BMC Womens Health       Date:  2021-01-06       Impact factor: 2.809

5.  Patterns and risk of HIV-1 transmission network among men who have sex with men in Guangxi, China.

Authors:  Xianwu Pang; Hui Wei; Jinghua Huang; Qin He; Kailing Tang; Ningye Fang; Xinjuan Zhou; Qiuying Zhu; Xiuling Wu; Guanghua Lan; Zhiyong Shen; Mei Lin; Shujia Liang
Journal:  Sci Rep       Date:  2021-01-12       Impact factor: 4.379

6.  HIV drug resistance and HIV transmission risk factors among newly diagnosed individuals in Southwest China.

Authors:  Xianwu Pang; Kailing Tang; Qin He; Jinghua Huang; Ningye Fang; Xinjuan Zhou; Qiuying Zhu; Xiuling Wu; Zhiyong Shen; Shujia Liang
Journal:  BMC Infect Dis       Date:  2021-02-08       Impact factor: 3.090

7.  Using Molecular Transmission Networks to Reveal the Epidemic of Pretreatment HIV-1 Drug Resistance in Guangxi, China.

Authors:  Fei Zhang; Bingyu Liang; Xu Liang; Zhaosen Lin; Yuan Yang; Na Liang; Yao Yang; Huayue Liang; Jiaxiao Jiang; Jiegang Huang; Rongye Huang; Shanmei Zhong; Cai Qin; Junjun Jiang; Li Ye; Hao Liang
Journal:  Front Genet       Date:  2021-09-10       Impact factor: 4.599

8.  Demographic characteristics and spatial clusters of recent HIV-1 infections among newly diagnosed HIV-1 cases in Yunnan, China, 2015.

Authors:  Min Chen; Yanling Ma; Huichao Chen; Jie Dai; Hongbing Luo; Chaojun Yang; Lijuan Dong; Xiaomei Jin; Min Yang; Li Yang; Lijun Song; Manhong Jia; Zhizhong Song
Journal:  BMC Public Health       Date:  2019-11-11       Impact factor: 3.295

9.  HIV-1 Drug Resistance, Distribution of Subtypes, and Drug Resistance-Associated Mutations in Virologic Failure Individuals in Chengdu, Southwest China, 2014-2016.

Authors:  Jiayi Chen; Yang Liu; Sijing Liu; Dan Yuan; Ling Su; Li Ye; Fanghong Gong; Yushuang Gao; Saira Baloch; Xiaofang Pei
Journal:  Biomed Res Int       Date:  2020-03-23       Impact factor: 3.411

10.  Characterization of subtypes and transmitted drug resistance strains of HIV among Beijing residents between 2001-2016.

Authors:  Jingrong Ye; Mingqiang Hao; Hui Xing; Yuncong Wang; Juan Wang; Yi Feng; Ruolei Xin; Ji Zeng; Shuai Zhao; Yinxiao Hao; Jing Chen; Yuhua Ruan; Xue Li; Yiming Shao; Hongyan Lu
Journal:  PLoS One       Date:  2020-03-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.